REQUEST A DEMO
Total
USD $0.00
Search more companies

Takeda Farmasyutikals OOO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing
Full name: Takeda Farmasyutikals OOO Profile Updated: June 27, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2017 Available in: English & Russian Download a sample report

Nycomed Distribution Sente (Russian representative Nycomed Pharma) is to research, manufacture and distribution of pharmaceuticals and other products for health care. Nycomed Pharma - one of the leading pharmaceutical companies in Scandinavia. Nycomed was founded in 1874 in Norway, with the production of drugs and for more than 125-year history, has made significant strides in the markets of the Benelux, Austria, Baltic States, CIS and other countries.

Headquarters
Ulitsa Usacheva, Dom 2, Str.1
Moscow; Moscow; Postal Code: 119048

Contact Details: Purchase the Takeda Farmasyutikals OOO report to view the information.

Website: http://takeda.com.ru

Basic Information
Total Employees:
Purchase the Takeda Farmasyutikals OOO report to view the information.
Registered Capital:
Purchase the Takeda Farmasyutikals OOO report to view the information.
Incorporation Date:
May 18, 1994
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
62%
Purchase this report to view the information.
38%
Company Performance
Financial values in the chart are available after Takeda Farmasyutikals OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
17.71%
Total operating revenue
17.71%
Operating profit (EBIT)
-27.7%
Net Profit (Loss) for the Period
-8.42%
Total assets
3.72%
Total equity
5.03%
Operating Profit Margin (ROS)
-2.15%
Net Profit Margin
-0.4%
Return on Equity (ROE)
-0.7%
Debt to Equity Ratio
-0.06%
Quick Ratio
0.16%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?